EMulate Therapeutics, Inc. Employee Directory
Biotechnology ResearchWashington, United States11-50 Employees
EMulate Therapeutics, founded in 2002 and headquartered in Seattle, Washington, operates as a clinical-stage biotechnology company. It has developed a non-invasive therapy that uses ultra-low radio frequency energy to regulate signaling and metabolic processes at the molecular and genetic level, delivered through a device called the Voyager. Its initial focus is on treating brain cancers for which conventional therapies often provide limited benefit and significant side effects. Beyond this, the company conducts pre-clinical work exploring other oncology applications and pain treatment, with potential relevance to veterinary medicine and non-medical domains. In 2023, EMulate Therapeutics participated in the SNO conference and published clinical results related to glioblastoma and DIPG.